Repligen
RGEN
#2397
Rank
HK$62.40 B
Marketcap
HK$1,106
Share price
-1.80%
Change (1 day)
18.47%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2026 (TTM): HK$0.60 Billion

According to Repligen 's latest financial reports the company's current earnings are HK$0.76 Billion. In 2025 the company made an earning of HK$0.65 Billion, an increase over its 2024 earnings that were of -HK$49.44 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$0.60 B-7.38%
2025 HK$0.65 B-1430.84%
2024 -HK$49.44 Million-113.01%
2023 HK$0.37 B-78.01%
2022 HK$1.72 B33.37%
2021 HK$1.29 B131.52%
2020 HK$0.55 B101.31%
2019 HK$0.27 B25.93%
2018 HK$0.22 B105.61%
2017 HK$0.10 B-11.46%
2016 HK$0.12 B14.91%
2015 HK$0.10 B20.26%
2014 HK$87.74 M-51.49%
2013 HK$0.18 B90.98%
2012 HK$94.7 M
2010 HK$1.37 M-103.81%
2009 -HK$35.98 Million-223.84%
2008 HK$29.04 M
2006 -HK$19.52 Million229.64%
2005 -HK$5.92 Million-89.16%
2004 -HK$54.63 Million-16.86%
2003 -HK$65.7 Million88.72%
2002 -HK$34.82 Million-27.88%
2001 -HK$48.27 Million-1.74%
2000 -HK$49.13 Million85.93%
1999 -HK$26.43 Million159.16%
1998 -HK$10.2 Million85.71%
1997 -HK$5.49 Million-70.83%
1996 -HK$18.83 Million-72.41%
1995 -HK$68.23 Million-60.63%
1994 -HK$0.18 Billion45.39%
1993 -HK$0.12 Billion39.45%
1992 -HK$85.48 Million-32.3%
1991 -HK$0.13 Billion6.62%
1990 -HK$0.12 Billion1577.78%
1989 -HK$7.06 Million-57.14%
1988 -HK$16.47 Million-362.5%
1987 HK$6.27 M-130.77%
1986 -HK$20.39 Million136.36%
1985 -HK$8.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$83.05 B 13,468.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$58.20 B 9,408.92%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$89.79 B 14,569.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$75.25 B 12,195.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-HK$0.87 Billion-241.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-HK$0.51 Billion-182.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$6.26 B 923.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
HK$1.22 B 100.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$3.02 B 394.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-HK$1.3 Billion-311.94%๐Ÿ‡บ๐Ÿ‡ธ USA